L.V.A.M. Beex
- Oncology top 5%
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 5
- Cancer Diagnosis and Treatment 4
- Bone health and treatments 2
-
- Breast Cancer Treatment Studies 5
- Orthopedics and Sports Medicine top 10%
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 5
-
- Estrogen and related hormone effects 9
-
- Chemotherapy-related skin toxicity 3
- Co-authors
- G.H. BlijhamHidde M. KroonO. L. M. BijvoetJ. HermansF. J. CletonJ.P. NeijtH.P. SleeboomSocrates E. Papapoulos
- Partner nations
- NetherlandsBelgiumUnited Kingdom
In The Last Decade
L.V.A.M. Beex
32 papers receiving 815 citations
Peers
Comparison fields: 5 of 80
- Oncology 573
- Cancer Research 119
- Orthopedics and Sports Medicine 67
- Radiology, Nuclear Medicine and Imaging 153
- Reproductive Medicine 51
Countries citing papers authored by L.V.A.M. Beex
This map shows the geographic impact of L.V.A.M. Beex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.V.A.M. Beex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.V.A.M. Beex more than expected).
Fields of papers citing papers by L.V.A.M. Beex
This network shows the impact of papers produced by L.V.A.M. Beex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.V.A.M. Beex. The network helps show where L.V.A.M. Beex may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L.V.A.M. Beex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 10 | |
| 2 | Mammaglobin remains a useful marker for the detection of breast cancer cells in peripheral blood. | 2005 | 1 |
| 3 | 2003 | 1 | |
| 4 | 2002 | 83 | |
| 5 | Quality of chemotherapy for malignant epithelial ovarian carcinoma in a non trial setting. | 1999 | 1 |
| 6 | Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G -> A point mutation (vol 21, pg 280, 1998) | 1998 | 1 |
| 7 | 1998 | 10 | |
| 8 | 1998 | 3 | |
| 9 | 1997 | 90 | |
| 10 | 1995 | 50 | |
| 11 | 1993 | 164 | |
| 12 | 1993 | 49 | |
| 13 | 1992 | 9 | |
| 14 | 1992 | 32 | |
| 15 | 1990 | 18 | |
| 16 | 1990 | 1 | |
| 17 | 1988 | 9 | |
| 18 | 1987 | 162 | |
| 19 | Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer. | 1987 | 14 |
| 20 | Cis-platin in combination with low dose adriamycin and cyclophosphamide in advanced ovarian carcinoma. | 1985 | 2 |
About L.V.A.M. Beex
L.V.A.M. Beex is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 33 papers that have together received 844 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (5 papers), Cancer Diagnosis and Treatment (4 papers), Chemotherapy-related skin toxicity (3 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Oncology (573 citations), Cancer Research (119 citations) and Orthopedics and Sports Medicine (67 citations). L.V.A.M. Beex has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include G.H. Blijham, Hidde M. Kroon, O. L. M. Bijvoet, J. Hermans, F. J. Cleton, J.P. Neijt, H.P. Sleeboom, Socrates E. Papapoulos, André B. P. Kuilenburg and H.I.J. Harinck. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.